Apolipoprotein C3 in diabetic nephropathy in type 1 diabetes and its role in cardiovascular disease

被引：0
|
作者：
Stechemesser, L. [1 ]
Forsblom, C. [2 ,3 ,4 ]
Tolonen, N. [2 ,3 ,4 ]
Taskinen, M. -R. [5 ]
Weitgasser, R. [6 ]
Groop, P. -H. [2 ,3 ,4 ]
机构：
[1] Paracelsus Med Univ LKH, Salzburg, Austria
[2] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[3] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Helsinki, Heart & Lung Ctr, Helsinki, Finland
[6] Diakonissen Wehrle Hosp, Dept Med, Salzburg, Austria
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1012
引用
收藏
页码：S497 / S497
页数：1
相关论文
共 50 条
  • [21] Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status
    Parente, E. B.
    Harjutsalo, V.
    Lehto, M.
    Forsblom, C.
    Groop, P. -H.
    DIABETOLOGIA, 2019, 62 : S517 - S518
  • [22] The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes
    Moellsten, Anna
    Lajer, Maria
    Jorsal, Anders
    Tarnow, Lise
    MOLECULAR GENETICS AND METABOLISM, 2009, 97 (01) : 80 - 84
  • [23] Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status
    Parente, Erika B.
    Harjutsalo, Valma
    Lehto, Markku
    Forsblom, Carol
    Sandholm, Niina
    Groop, Per-Henrik
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [24] Nephrinuria in diabetic nephropathy of type 1 diabetes
    Pätäri, A
    Forsblom, C
    Havana, M
    Taipale, H
    Groop, PH
    Holthöfer, H
    DIABETES, 2003, 52 (12) : 2969 - 2974
  • [25] ASSOCIATION OF DIABETIC NEPHROPATHY WITH INSTRUMENTS FOR PREDICTION OF CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 1 DIABETES
    Goldshmid, A.
    Fadeyev, V.
    Poluboyarinova, I.
    Karamullina, R.
    Chechikova, E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A196 - A196
  • [26] Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes
    Alborn, William E.
    Prince, Melvin J.
    Konrad, Robert J.
    CLINICA CHIMICA ACTA, 2007, 378 (1-2) : 154 - 158
  • [27] Serum Apolipoprotein C-III and Cardiovascular Events in Type 1 Diabetes
    Basu, Arpita
    Bebu, Ionut
    Jenkins, Alicia
    Stoner, Julie
    Zhang, Ying
    Klein, Richard L.
    Lopes-Virella, Maria F.
    Garvey, W. Timothy
    Budoff, Matthew
    Lyons, Timothy
    DIABETES, 2018, 67
  • [28] Genetic exploration of a causal role of dyslipidaemia on diabetic nephropathy in type 1 diabetes
    Dahlstrom, E. H.
    Todd, J.
    Sandholm, N.
    Salem, R.
    Forsblom, C.
    Tolonen, N.
    Harjutsalo, V.
    Hirschorn, J.
    Florez, J. C.
    Groop, P. -H.
    DIABETOLOGIA, 2015, 58 : S527 - S527
  • [29] A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
    Waden, Johan
    Forsblom, Carol
    Thorn, Lena M.
    Gordin, Daniel
    Saraheimo, Markku
    Groop, Per-Henrik
    DIABETES, 2009, 58 (11) : 2649 - 2655
  • [30] Effect of Aging on Risk of Cardiovascular Disease in Type 2 Diabetes Patients with, or without Diabetic Nephropathy
    Sekimizu, Kenichi
    Watanabe, Kentaro
    Ouchi, Motoshi
    Suzuki, Kazunari
    Suzuki, Tatsuya
    Nakano, Hiroshi
    Oba, Kenzo
    DIABETES, 2011, 60 : A562 - A562
12345